Home/Charleston Laboratories/Paul Bosse

PB

Paul Bosse

Founder and CEO

Charleston Laboratories

Therapeutic Areas

Acute Pain Management Supportive Care (Nausea/Vomiting)

Charleston Laboratories Pipeline

Drug	Indication	Phase
CL-108	Moderate to Severe Acute Pain with prevention/reduction of Opioid-Induced Nausea and Vomiting (OINV)	NDA Resubmitted

Leadership Team at Charleston Laboratories

Raymond A. Dionne

Scientific/Clinical Advisor (inferred from news)

View full Charleston Laboratories profile